ATYR PHARMA INC's ticker is and the CUSIP is 002120902. A total of 3 filers reported holding ATYR PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,908 | -47.9% | 12,600 | -28.8% | 0.00% | – |
| Q2 2023 | $38,232 | +2934.3% | 17,700 | +2850.0% | 0.00% | – |
| Q1 2023 | $1,260 | -76.0% | 600 | -75.0% | 0.00% | – |
| Q4 2022 | $5,256 | -12.4% | 2,400 | +26.3% | 0.00% | – |
| Q3 2022 | $6,000 | -68.4% | 1,900 | -47.2% | 0.00% | – |
| Q1 2022 | $19,000 | +90.0% | 3,600 | +157.1% | 0.00% | – |
| Q4 2021 | $10,000 | -97.7% | 1,400 | -97.1% | 0.00% | – |
| Q3 2021 | $431,000 | – | 47,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 47,500 | $431,000 | 0.00% |
| SIMPLEX TRADING, LLC | 5,200 | $26,000 | 0.00% |